ConvaTec prevails in patent case brought by Smith & Nephew
Dec 19, 2012
ConvaTec, a world-leading developer of innovative medical
technologies, is pleased to announce that the Court of Appeal in
the Royal Courts of Justice in the United Kingdom has upheld a
previous court's decision validating ConvaTec's patent for
its innovative design and manufacturing process for producing
silver wound dressings.
This mirrors a similar decision in the European Patent Office
last month that ConvaTec's patents for silver wound dressings
around Europe are valid.
ConvaTec's AQUACEL® Ag wound dressings include ionic
silver, which kills harmful bacteria.
"We were pleased with the original court's decision to uphold
our patent and are gratified with this new ruling against Smith
& Nephew's appeal," said Ken Berger, CEO. "This ruling
recognizes ConvaTec's scientific innovation in the wound care area
and the need to protect such work."
ConvaTec's AQUACEL® wound dressings have a
gel-forming wound contact layer that promotes healing and protects
against infection. The AQUACEL® Ag wound dressing
adds ionic silver for even more protection against harmful
bacteria.
About ConvaTec
ConvaTec is a leading developer and marketer of innovative medical
technologies that have helped improve the lives of millions of
people worldwide. With four key focus areas - Ostomy Care,
Wound Therapeutics, Continence and Critical Care, and Infusion
Devices - ConvaTec products support healthcare professionals from
the hospital to the community health setting. The company has
world class manufacturing on nearly every continent and a
production network of 12 plants in nine countries. For more
information, please visit www.convatec.com
About Nordic Capital Private Equity Funds
Since the start in 1989, Nordic Capital Private Equity Funds
have invested in large and medium sized companies, primarily in
Northern Europe. Through committed ownership and by targeting
strategic development and operational improvements, Nordic Capital
creates value in its investments. The funds invest in companies in
Northern Europe and in selected investment opportunities
internationally. They are based in Jersey, Channel Islands, and are
advised by the NC Advisory companies in Sweden, Denmark, Finland,
Norway, Germany and the UK. Additional information about Nordic
Capital is available through its corporate website, www.nordiccapital.com.
Back to news listings >
